('figure', 32);('backward bifurcation', 21);('vaccine e\x0ecacy', 17);('backward bifurcations', 17);('r0', 15);('vaccine coverage', 13);('endemic equilibria', 12);('e ect', 11);('heterogeneity', 11);('i+', 11);('parameters', 10);('covid-19', 9);('basic reproductive ratio', 9);('population heterogeneity', 9);('backward', 8);('ci', 7);('+ \x17+\x16', 7);('infectious diseases', 6);('vaccination rate', 6);('alina glaubitz', 6);('vaccine coverage heterogeneity', 6);('bifurcation dynamics', 5);('feng fu', 5);('transmission rate', 5);('mathematical biosciences', 5);('epidemic model', 5);('model parameters', 4);('heterogeneity in vaccine coverage impacts epidemic thresholds and bifurcation dynamics', 4);('c1', 4);('vi', 4);('ii', 4);('p1=0.5', 4);('p2=0.5', 4);('vaccine efficacy', 4);('= 1=', 4);('fu', 4);('feng', 4);('applied mathematics', 4);('applications', 4);('mathematical', 4);('population', 3);('infectious disease dynamics', 3);('i. e.', 3);('mathematics', 3);('sir', 3);('r0=', 3);('endemic disease', 3);('dynamical behavior', 3);('imperfect vaccines', 3);('sirv', 3);('subsection', 3);('rate i', 3);('vaccination', 3);('+\x16+ 1+', 3);('sdfe', 3);('vdfe', 3);('endemic equilibrium', 3);('sis', 3);('homogeneous population', 3);('relative group size', 3);('homophily', 3);('pmid', 3);('p.', 3);('global', 3);('siam', 3);('c. castillo-chavez', 3);('disease transmission', 3);('driessche', 3);('mathematical analysis', 3);('transmission dynamics', 2);('vaccine-preventable diseases', 2);('vaccine hesitancy', 2);('vaccination coverage', 2);('di erences', 2);('practical implications', 2);('epidemic control', 2);('health initiative', 2);('school immunization requirements', 2);('dartmouth', 2);('nh', 2);('usa', 2);('bifurcation occurs', 2);('compartmental models', 2);('e ective', 2);('hiv/aids', 2);('malaria', 2);('h1n1', 2);('one-group scenario', 2);('introduce heterogeneity', 2);('rates i', 2);('vaccine', 2);('2i2\x01 \x00', 2);('ri', 2);('pi\x00', 2);('explicit formula', 2);('ij', 2);('fv\x001', 2);('r0=1', 2);('disease-free equilibrium', 2);('i=i1+i2', 2);('hence', 2);('r0increases', 2);('real root', 2);('rbb', 2);('imperfect vaccine', 2);('vaccine coverage causes backward bifurcations', 2);('backward bifurcation occurs', 2);('e ects', 2);('relative', 2);('group size matters', 2);('\x0e =', 2);('interestingly', 2);('di erent vaccine coverage', 2);('nature', 2);('modelling', 2);('proceedings', 2);('royal society', 2);('salath\x13', 2);('marcel', 2);('] https', 2);('interface', 2);('herd immunity', 2);('k.p', 2);('hadeler', 2);('christopher m. kribs-zaleta', 2);('a.b', 2);('gumel', 2);('gumel ab', 2);('apr', 2);('van den', 2);('d.', 2);('chinviriyasit', 2);('vaccine coverage impacts epidemic thresholds', 1);('alina glaubitz\x03andfeng fu\x03y abstract', 1);('contact networks', 1);('important role', 1);('outstanding issues', 1);('nonuniform coverage', 1);('pandemic transitions', 1);('signi cance', 1);('aforementioned population heterogeneity', 1);('persis- tence', 1);('analyze epidemic thresholds', 1);('characterize bifurcation dynamics', 1);('group-dependent characteristics', 1);('disease transmissibility', 1);('analysis shows', 1);('di erence', 1);('multiple equilibria', 1);('disease burden', 1);('heterogeneity factors', 1);('group size', 1);('exhibit subtle impacts', 1);('backward bifurcations whereas', 1);('aggra- vate disease endemicity', 1);('public health e orts', 1);('key', 1);('public health', 1);('introduction', 1);('resurgence', 1);('surprising comeback', 1);('low vaccination rates', 1);('disease control e orts [', 1);('phrase \\the pandemics', 1);('civil dis- course', 1);('mass vaccination campaign [', 1);('public health stakeholders', 1);('various forms', 1);('doing', 1);('global populations [', 1);('concerning', 1);('pandemic [', 1);('epidemics [', 1);('various aspects', 1);('contacts [', 1);('vaccine uptake [', 1);('furthermore', 1);('di erent vaccines', 1);('di erent e\x0ecacies [', 1);('di erent levels', 1);('vaccine e\x0ecacies', 1);('di erent age groups [', 1);('nonmedical exemptions', 1);('measures [', 1);('similar opinions [', 1);('social interactions', 1);('hanover', 1);('alina.glaubitz.gr @ dartmouth.edu', 1);('feng.fu @ dartmouth.edu', 1);('biomedical data', 1);('geisel', 1);('medicine', 1);('lebanon', 1);('1arxiv:2212.13951v1 [ q-bio.pe ]', 1);('dec', 1);('infectious diseases [', 1);('ever', 1);('] rst', 1);('susceptible-infected-recovered', 1);('mental models', 1);('] .r0is', 1);('epidemic threshold parameter', 1);('index case', 1);('disease outbreak', 1);('r0measures', 1);('secondary infections', 1);('susceptible population', 1);('relating', 1);('r0to', 1);('common epidemic models', 1);('forr0 <', 1);('stable disease-free equilibrium', 1);('forr0 >', 1);('unstable disease-free equilibrium', 1);('stable endemic equilibrium [', 1);('epidemic threshold', 1);('outbreak occurs', 1);('real-world scenarios', 1);('r0becomes', 1);('di erent groups', 1);('predictive character', 1);('unstable endemic equilibrium co-exist', 1);('introduce backward bifurcation', 1);('rst discovery', 1);('treatment availability', 1);('non-linear incidence rate', 1);('non-constant contact rates', 1);('partial protection', 1);('transmission rates', 1);('imperfect lockdowns [', 1);('combination models', 1);('dengue', 1);('built', 1);('present study aims', 1);('multiple groups', 1);('imperfect vaccination', 1);('importantly', 1);('wide range', 1);('impact conditions', 1);('speci c', 1);('group-dependent heterogeneity', 1);('analytical ndings', 1);("model 's epidemic thresholds", 1);('present numerical results', 1);('potential implications', 1);('model', 1);('compartmental model', 1);('popu- lation', 1);('groups f1', 1);('relative sizes', 1);('p1andp2respectively', 1);('p1+p2=', 1);('extending', 1);('con rm', 1);('similar results', 1);('indi- vidual', 1);('susceptible individuals', 1);('group iget', 1);('in-', 1);('partial immunity', 1);('susceptible compartment', 1);('i2 f1', 1);('di erent e\x0ecacies', 1);('susceptibility', 1);('individuals', 1);('group iare', 1);('rate iwhen', 1);('contact rates', 1);('population group', 1);('p2c1', 1);('accordingly', 1);('_si=\x16pi+\x17ri\x00si i\x00', 1);('si+ vi', 1);('2i2\x01 + isi\x00', 1);('si+', 1);('ii\x00', 1);('fori2 f1', 1);('initial condition', 1);('si', 1);('=s0 i', 1);('=v0 i', 1);('=i0 i', 1);('s0', 1);('i+v0 i+i0 i', 1);('exhibits backward bifurcations', 1);('cer- tain conditions', 1);('simpler cases', 1);("model's dynamical behavior", 1);('corresponding homogeneous population', 1);('exhibit backward bifur- cations', 1);('conditions for4', 1);('feng fu s1v1i1i2r1r21', 1);('s2v222', 1);('schematic', 1);('more-', 1);('r0and', 1);('present comparative results', 1);('conditions', 1);('full model', 1);('analytical intuitions', 1);('equal size', 1);('base case', 1);('general results', 1);('next-generation method', 1);('following', 1);('new infections', 1);('fj', 1);('vj', 1);('f=', 1);('fi', 1);('population heterogeneity in vaccine coverage impacts epidemic thresholds and bifurcation dynamics', 1);('+\x16+ 2\x13', 1);('dfe', 1);('i= +\x16 + i+\x16pi', 1);('i = i + i+\x16pi', 1);('=2 > +\x16', 1);('ri= iias', 1);('+ \x17+\x16\x11', 1);('si=', 1);('i+ +\x16', 1);('ii=', 1);('pi', 1);('i+ i', 1);('+ i', 1);('p1', 1);('p2', 1);('i=', 1);('exact solutions', 1);('iand', 1);('i1andi2', 1);('might lead', 1);('reasonable solutions', 1);('discriminant \x01 = 256a3e3\x00192a2bde2\x00128a2c2e2+ 144a2cd2e\x0027a2d4+ 144ab2ce2 \x006ab2d2e\x0080abc2de+ 18abcd3+ 16ac4e4ac3d2\x0027b4e2+ 18b3cde \x004b3d3\x004b2c3e+b2c2d2', 1);('complex conjugate solutions', 1);('complex conjugate root', 1);('double root', 1);('critical threshold', 1);('system exhibits backward bifurcation', 1);('stability properties', 1);('depending', 1);('population heterogneity', 1);('observe di erent behaviors', 1);('vaccine uptake rates', 1);('heterogeneity \x0e', 1);('absolute di erence', 1);('susceptibility \x0e', 1);('vaccine e\x0ecacy \x0e', 1);('exact compositions', 1);("model 's behavior", 1);('subtle impacts', 1);('equilibria', 1);('mathematica', 1);('solve', 1);('eq', 1);('susceptibility destabilizes', 1);('vaccine e\x0ecacy stabilizes', 1);('relative group size matters', 1);('such group size e ect', 1);('population heterogene- ity', 1);('feng fu figure', 1);('= 0:05. coverage', 1);('impact', 1);('equilib- rium disease burden', 1);('numerical simulations', 1);('analytical solutions', 1);('model changes', 1);('similar others', 1);('i >', 1);('r0constant', 1);('vaccine e\x0e- cacy', 1);('vaccine efficacy heterogeneity', 1);('vaccine e\x0ecacy heterogeneity', 1);('= 0:9.', 1);('+\x16+ 2+ \x12', 1);('2p1p2 +\x16+', 1);('c2', 1);('a1=21 ca:10 alina glaubitz', 1);('vaccine ecacy', 1);('heterogeneous populations', 1);('matlab', 1);('method ode23', 1);('bogacki', 1);('shampine', 1);('runge', 1);('kutta', 1);('r0is', 1);('i. e. contact', 1);('typically', 1);('group prevents', 1);('people interact', 1);('r0because', 1);('intergroup interactions', 1);('observation applies', 1);('small number', 1);('r0passes', 1);('vaccine uptake', 1);('discussion', 1);('conclusion', 1);('e. g.', 1);('e. g. [', 1);('additional heterogeneity', 1);('particularly', 1);('additional subtle e ects', 1);('common assumption', 1);('work stresses', 1);('endemic diseases', 1);('di erent vaccine uptake rates', 1);('di erent vaccine e\x0ecacies', 1);('backward bifurcation behavior', 1);('important factor', 1);('disease endemicity', 1);('joint e ect', 1);('endemic disease model', 1);('profound e ect', 1);('world embraces', 1);('mass vaccination', 1);('major intervention', 1);('local communities', 1);('post-pandemic era', 1);('competing', 1);('acknowledgement', 1);('f.f', 1);('bill', 1);('melinda gates', 1);('opp1217336', 1);('nih cobre program', 1);('grant no.1p20gm130454', 1);('neukom compx faculty grant', 1);('dartmouth faculty startup', 1);('walter', 1);('constance burke', 1);('initiation award.', 1);('references', 1);('bloom', 1);('barry r', 1);('marcuse', 1);('edgar', 1);('mnookin', 1);('seth', 1);('addressing', 1);('bor', 1);('alexander', 1);('frederik', 1);('petersen', 1);('michael bang', 1);('discriminatory attitudes against', 1);('unvaccinated', 1);('global pandemic', 1);('rubin', 1);('carol', 1);('myers', 1);('tanya', 1);('stokes', 1);('william', 1);('dunham', 1);('bernadette', 1);('harris', 1);('stic', 1);('lautner', 1);('beth', 1);('annelli', 1);('joseph', 1);('review', 1);('national research council recommendations', 1);('emerging', 1);('vespignani', 1);('alessandro', 1);('tian', 1);('huaiyu', 1);('dye', 1);('christopher', 1);('nature reviews physics', 1);('number', 1);('royce', 1);('katherine', 1);('mathematically', 1);('infectious zoonosis', 1);('intermediate host', 1);('plos', 1);('glaubitz', 1);('alina', 1);('oscillatory', 1);('alexandra teslya', 1);('hendrik nunner', 1);('vincent buskens', 1);('mirjam e kretzschmar', 1);('health opinions', 1);('epidemic dynamics', 1);('pnas nexus', 1);('november', 1);('//doi.org/10.1093/pnasnexus/pgac260 [', 1);('may', 1);('robert', 1);('lloyd', 1);('alun l. infection', 1);('scale-free networks', 1);('physical review e', 1);('wang', 1);('zhen', 1);('bauch', 1);('chris t', 1);('bhattacharyya', 1);('samit', 1);('alberto', 1);('manfredi', 1);('piero', 1);('perc', 1);('matja\x14', 1);('perra', 1);('nicola', 1);('zhao', 1);('dawei', 1);('statistical', 1);('physics', 1);('02/16/2022 [', 1);('antia', 1);('ahmed h', 1);('handel', 1);('carlson', 1);('amanna ij', 1);('antia r', 1);('slifka m. heterogeneity', 1);('antibody memory', 1);('plos biol', 1);('aug', 1);('10.1371/jour- nal.pbio.2006601', 1);('pmcid', 1);('pmc6105026', 1);('collier', 1);('d.a.', 1);('ferreira', 1);('i.a.t.m.', 1);('kotagiri', 1);('age-related', 1);('immune response heterogeneity', 1);('sars- cov-2', 1);('bnt162b2', 1);('//doi.org/10.1038/s41586-021-03739-1 [', 1);('chen', 1);('xingru', 1);('imperfect', 1);('royal society b', 1);('kadelka', 1);('claus', 1);('mccombs', 1);('audrey', 1);('general infectious disease outbreaks', 1);('plos one', 1);('16:1-20. doi', 1);('10.1371/journal.pone.0260973 [', 1);('john', 1);('glasser', 1);('zhilan feng', 1);('saad', 1);('omer', 1);('philip j smith', 1);('lance e rodewald', 1);('rubella vaccine', 1);('poten- tial', 1);('lancet infectious diseases', 1);(':599-605. https', 1);('fe', 1);('nina h.', 1);('silk', 1);('matthew j.', 1);('pasquale', 1);('dana k.', 1);('moody', 1);('james', 1);('behavior complicate understanding', 1);('covid-', 1);('epidemic curve', 1);('2021. doi', 1);('mcpherson', 1);('miller', 1);('smith-lovin', 1);('lynn', 1);('cook', 1);('james m.', 1);('social networks', 1);('annual', 1);('nowak', 1);('martin', 1);('christakis', 1);('nicholas', 1);('fowler', 1);('james h.', 1);('scienti', 1);('c reports', 1);(':1 {', 1);('bonhoe', 1);('sebastian', 1);('disease outbreaks', 1);(':1505 {', 1);('may t', 1);('silverman rd', 1);('clustering', 1);('collective action threat', 1);(':1048 { 1051. pmid:12559778 [', 1);('omer sb', 1);('enger ks', 1);('moulton lh', 1);('halsey na', 1);('stokley', 1);('salmon da', 1);('geographic', 1);('nonmed- ical exemptions', 1);('american journal', 1);('epidemiology', 1);(':1389 { 1396. pmid:18922998 [', 1);('//covid.cdc.gov/covid-data-tracker/ # county-view', 1);('kermack william ogilvy', 1);('mckendrick a. g.', 1);('mathematical theory', 1);('proc', 1);('r. soc', 1);('lond', 1);('a115700', 1);('j.m', 1);('smith r.j', 1);('wahl l.m', 1);('perspectives', 1);('j. r. soc', 1);('hethcote', 1);('herbert w.', 1);('siam review', 1);(':599-653. doi', 1);('li', 1);('michael y.', 1);('hal smith', 1);('liancheng wang', 1);('seir epidemic model', 1);('vertical transmission', 1);('{ 69. doi', 1);('core group model', 1);('mathematical bio-', 1);(':41-55. https', 1);('p. van', 1);('mathematical bio-population heterogeneity in vaccine coverage impacts epidemic thresholds and bifurcation dynamics', 1);(':15-35. https', 1);('fred brauer', 1);('simple vaccination models', 1);(':418-431. https', 1);('jorge x. velasco-hern\x13', 1);('simple vaccination model', 1);('multi- ple endemic states', 1);(':183-201. https', 1);('jing hui', 1);('deming zhu', 1);('epidemic models', 1);('computers', 1);(':1271-1290. https', 1);('maia martcheva', 1);('backward bifurca- tion', 1);('177-178:317-332. https', 1);('k. nudee', 1);('s. chinviriyasit', 1);('w. chinviriyasit', 1);('measles transmission', 1);('chaos', 1);('solitons', 1);('fractals', 1);('123:400-412. doi', 1);('s.m', 1);('garba', 1);('m.r', 1);('abu bakar', 1);('dengue transmission dy- namics', 1);(':11-25. doi', 1);('//doi.org/10.1016/j.mbs.2008.05.002 [', 1);('sharomi', 1);('podder cn', 1);('mahmud sm', 1);('rubinstein e. modelling', 1);('bull math biol', 1);('mar', 1);(':515- 48. doi', 1);('epub', 1);('james watmough', 1);('reproduction', 1);('sub-threshold endemic equilibria', 1);(':29-48. https', 1);('xu zhang', 1);('xianning liu', 1);('treat- ment function', 1);(':433-443. https', 1);('wendi wang', 1);(':58-71. https', 1);('buonomo', 1);('b.', 1);('lacitignola', 1);('seir', 1);('convex incidence rate', 1);('ricerche', 1);('//doi.org/10.1007/s11587-008-0039-4 [', 1);('buonomo b.', 1);('lacitignola d.', 1);('vaccination model', 1);('nonlinear incidence', 1);('nonlinear analysis', 1);('30-46. doi', 1);('10.15388/na.16.1.14113 [', 1);('] van den', 1);('watmough', 1);('j math biol', 1);('//doi.org/10.1007/s002850000032 [', 1);('greenhalgh', 1);('david', 1);('diekmann', 1);('odo', 1);('de jong', 1);('mart', 1);('subcritical', 1);('steady states', 1);('mathematical models', 1);('animal infections', 1);('incomplete immunity', 1);('z. feng', 1);('f. capurro', 1);('exogenous reinfection', 1);('theor', 1);('popul', 1);('biol.', 1);('k. cooke', 1);('w. huang', 1);('s.a. levin', 1);('sexual transmission', 1);('human immunode ciency virus', 1);(':327-331. https', 1);('nadim ss', 1);('chattopadhyay j', 1);('occurrence', 1);('imperfect lockdown', 1);('case study', 1);('chaos solitons fractals', 1);('140:110163. doi:10.1016/j.chaos.2020.110163 [', 1);('causes', 1);('epidemiological models', 1);(':355-365. https', 1);('huang', 1);('wenzhang', 1);('cooke', 1);('kenneth l.', 1);('castillo-chavez', 1);('carlos', 1);('stability', 1);('bifurcation', 1);('multiple-group model', 1);('dynamics', 1);('hiv/aids transmission', 1);(':835-854. doi:10.1137/0152047', 1);('roop-o', 1);('pariyaporn', 1);('wirawan', 1);('sttapat', 1);('incidence function', 1);('malaria model', 1);('temporary immunity', 1);('bio- sciences', 1);('mukandavire z', 1);('garira', 1);('tchuenche jm', 1);('hiv-malaria', 1);('math biosci eng', 1);(':333-62. doi', 1);('asatryan', 1);('ani', 1);('wodarz', 1);('dominik', 1);('komarova', 1);('natalia l.', 1);('new virus dynamics', 1);('multiple infection', 1);('theoretical biology', 1);('arino j.', 1);('connell mccluskey c.', 1);('driessche p.', 1);('exhibits backward bifurcation', 1);('{ 76. http', 1);('auckly', 1);('solving', 1);('quartic', 1);('pencil', 1);('burgio', 1);('giulio', 1);('vaccine roll-outs', 1);('takayuki hiraoka', 1);('abbas k. rizi', 1);('mikko kivel\x7f', 1);('jari saram\x7f', 1);('epidemic size', 1);('networks', 1);('vaccination homophily', 1);